ODDB.org: Open Drug Database

Alexion Pharma GmbH - Ultomiris 300 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	67278	Sequence	02
Product name	Ultomiris 300 mg/3 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L04AA43	ATC-Description	Ravulizumab
Introduction of Sequence	16.09.2021

Composition

ravulizumabum 300 mg, natrii dihydrogenophosphas, dinatrii phosphas, argininum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 4.6 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Ravulizumabum	300mg / 3ml

BAG: Active Agent	Dose
Ravulizumabum	300 mg

Inactive agents
Arginine
Disodium Phosphate
Natrii Dihydrogenophosphas
Polysorbatum 80
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002		4035.61	4181.60	A	SL	Yes

2025	©ywesee GmbH